Skip to content

May 2026

Anxiety

What May 2026's 25 new studies found, synthesized from the papers below. All Anxiety research →

The synthesis

Synthesized from 25 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for Anxiety, generalized anxiety disorder, GAD, panic disorder, anxiety disorder, then ranked by relevance.

Research published in May 2026 indicates that mindfulness-based interventions and psychedelic-assisted therapies show promise for reducing anxiety symptoms, with meta-analyses reporting large within-group effects for psilocybin-assisted psychotherapy (Hedge's g = 0.96) and significant reductions from VR-based mindfulness. However, evidence is mixed and limited by high heterogeneity, small sample sizes, and a lack of long-term follow-up, so conclusions about durability and generalizability remain cautious.

Evidence by study

Direction is which way each study's own result points, not our rating of the study.

What the directions mean
Supports:
the study found the intervention worked, or its hypothesis held.
Opposes:
it found the opposite, no benefit or a harm.
No effect:
no significant difference either way.
Mixed:
effects in both directions within the same study.
Unclear:
the abstract does not report a direction.

Emotional authenticity was negatively associated with dream anxiety themes, and self-punishment fully mediated this relationship.

quantitative correlational survey design Sample size: 555

Internet-based B-MBCT plus treatment-as-usual led to significantly greater reductions in anxiety, depression, stress, and illness perception compared with treatment-as-usual alone, with large effect sizes.

pilot randomized controlled trial Sample size: 18

Psychedelics such as psilocybin, MDMA, and ayahuasca show promising results for anxiety and other psychiatric disorders, especially when paired with supervised psychotherapy.

narrative review

Psilocybin-assisted psychotherapy produced a large within-groups effect (Hedge's g = 0.96) and a small between-groups effect (Hedge's g = 0.48) on anxiety symptoms, but high heterogeneity and variability in study quality warrant caution.

systematic review Sample size: 25

Mindfulness and spirituality mediated the link between connection to nature and psychological wellbeing, but their roles varied depending on how constructs were measured; mindful attention reduced anxiety in one study, while spirituality did not mediate anxiety in another.

cross-sectional survey Sample size: 399

Argues that current anxiolytic drugs have limited efficacy and side-effects, and that there remains a major need for improved medications, including psychedelic-assisted therapies.

editorial

Mindfulness-based interventions reduce competitive anxiety in athletes, with the type of control group moderating the effect size.

systematic review and meta-analysis

Mindfulness-based interventions improve emotion regulation and may indirectly reduce anxiety in Deaf and Hard-of-Hearing students, though most interventions use broader approaches and experimental evidence is lacking.

systematic review with bibliometric analysis Sample size: 10

VR-based mindfulness interventions were associated with significant reductions in depressive and anxiety symptoms, with larger effects among older adults and in Eastern regions.

meta-analysis Sample size: 864

Mindfulness is associated with reduced psychological distress and may facilitate pro-environmental action through climate anxiety.

observational study

A one-week intensive mindfulness-based skills training program reduced tension-anxiety and fatigue but also increased depression and perceived stress.

pre-post intervention study Sample size: 14

Flumazenil, midazolam, and ketamine modulate anxiety-like behavior in rats, as evidenced by changes in aversive ultrasonic vocalizations and elevated plus maze performance.

experimental study

Both Vipassana and Shamatha meditation techniques significantly reduced test anxiety and negative affect and increased positive automatic thoughts and positive affect, with Shamatha showing a slightly better effect on test anxiety.

open-label randomized trial Sample size: 200

Serotonergic psychedelics, especially psilocybin, exerted anxiolytic-like effects in animal models, but anxiogenic and null effects were also reported, indicating context-dependent effects.

systematic review Sample size: 18

Argues that anxiety is neurobiologically based and that HPA axis activation is the fundamental mechanism generating anxiety, while psychoanalytic concepts of anxiety are recognized in neuroscience only as signal anxiety.

theoretical or philosophical paper

Mindfulness-based and somatic interventions, especially EVE and Body Mapping, improved emotional and attentional regulation and reduced anxiety in musicians, with EVE potentially surpassing traditional mindfulness due to vagus nerve stimulation.

pre-post intervention study with active control and no-intervention group Sample size: 50

Nonattachment reduced perceived stress indirectly by attenuating distress from self-discrepancies, but self-discrepancy did not directly correlate with perceived stress, and three nonself measures showed positive associations with stress.

cross-sectional survey with regression-based path analysis Sample size: 181

A Kriya yoga intervention reduced anxiety, increased alpha band activity, decreased high-beta activity, and improved respiratory signals in students with elevated anxiety.

observational cohort with pre-post intervention Sample size: 550

Activation of the prelimbic cortex to zona incerta circuit restored exploratory deficits and alleviated other depression-like behaviors in depressed mice, but the study focused on depression rather than anxiety.

experimental study

Mindfulness training reduced stress-induced anxiety and perceived stress in military drivers.

quasi-experimental study Sample size: 95

Argues that no single scale fully captures the complexity of mental health, and that combining well-being and distress measures provides a more comprehensive understanding in intervention studies.

systematic review

Argues that research on psychedelics and psychosis/madness should be interdisciplinary, methodologically expansive, and careful about speaking 'for' subjects, drawing on a concept of 'integration' from earlier psychosis research.

theoretical or philosophical paper

Argues that integrated yoga practices, when tailored to symptom clusters and administered safely, can serve as an effective adjunct therapy to improve coping, self-awareness, and quality of life in major psychological disorders, including anxiety.

clinical protocol development

Argues that Indian music and mantra therapy may improve psychological well-being by enhancing attentional control, emotional balance, and autonomic regulation, but notes the need for standardized and longitudinal studies.

review

The protocol outlines a planned trial to evaluate psilocybin as an adjunct to virtual reality exposure therapy for social anxiety disorder; no findings are reported.

randomized controlled trial

Points of agreement

  • Mindfulness-based interventions consistently reduce anxiety symptoms across diverse populations, including athletes, students, drivers, and post-AMI patients.
  • Psychedelic-assisted therapies, particularly psilocybin, show promise for reducing anxiety, though effects are often context-dependent and require further study.
  • Yoga and meditation practices are associated with reduced anxiety and improved emotional regulation.
  • Mindfulness and spirituality may mediate the relationship between nature connection and psychological wellbeing, but their roles vary by measurement.

Conflicts

  • Some studies report null or anxiogenic effects of psychedelics in animal models, contrasting with positive findings in human trials.
  • An intensive mindfulness program reduced tension-anxiety but increased depression and perceived stress, suggesting potential adverse effects in some contexts.
  • The role of spirituality as a mediator is inconsistent: one study found it significant, another did not.

Gaps

  • Most studies lack long-term follow-up, so durability of anxiety reduction is unclear.
  • Many trials have small sample sizes (e.g., 14, 18, 50) and are pilot or quasi-experimental, limiting generalizability.
  • There is a lack of standardized protocols for mindfulness and psychedelic interventions, contributing to high heterogeneity.
  • Few studies include diverse populations or specific subgroups (e.g., deaf/hard-of-hearing, clinical anxiety disorders).
  • The planned RCT for psilocybin and VR exposure therapy has no results yet.
Browse these studies in the library